🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 16

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 16 of 20
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Sep 20, 2024 at 8:18 PM#76
Dr.PathRoch said:
Keep the original post as written when you update it, and add the correction underneath.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.

Last edited: Sep 20, 2024 at 10:18 PM
41 16pete_RVA, CarlaRPh_TPA, steph_laguna and 38 others
Reply Quote Save Share Report
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Sep 24, 2024 at 6:47 AM#77

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

40 15paige_pharma, emma_london, tammy_FL and 37 others
Reply Quote Save Share Report
JakeBK_lifts
Member
523
2,345
Jul 2024
Brooklyn, NY
Sep 27, 2024 at 5:14 PM#78
anna.melb_AU said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This is my experience too, for whatever a second data point is worth. The detail I would add is minor and it is already implied above.

39 14LabKate, kate.chem, DataDave and 36 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
fiona_VT
Member
178
890
Dec 2024
Vermont
Oct 1, 2024 at 3:39 AM#79
anna.melb_AU said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding the part of the answer the thread has not reached. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Oct 1, 2024 at 4:39 AM
38 13chris_chi24, tampaLisa73, KarenAZ_mom and 35 others
Reply Quote Save Share Report
Dr.GutHealth
Senior Member
1,456
7,890
Mar 2024
Minnesota
Oct 4, 2024 at 2:02 PM#80

One concrete data point for the thread. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

16 16MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 13 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register